| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13D · 6 securities · may seek to influence control | ||||||
|
Monte Rosa Therapeutics, Inc.
13D/A
GLUE · 61225M102
|
7.9% |
7/6/2026
Event 7/1/2026
|
||||
| New Enterprise Associates 17, L.P. | 7.9% | |||||
| NEA Partners 17, L.P. | 7.9% | |||||
| Nea 17 GP, LLC | 7.9% | |||||
| Anthony A. Florence, Jr. | 7.9% | |||||
| Mohamad H. Makhzoumi | 7.9% | |||||
| Scott D. Sandell | 7.9% | |||||
| Forest Baskett | 0% | |||||
| Ali Behbahani | 0.2% | |||||
| Carmen Chang | 0% | |||||
| Edward T. Mathers | 0% | |||||
| Paul Walker | 0% | |||||
| Rick Yang | 0% | |||||
|
Inventiva S.A.
13D/A
IVA · 46124U107
|
4.9% |
4/1/2026
Event 3/30/2026
|
||||
| New Enterprise Associates 17, L.P. | 4.9% | |||||
| NEA Partners 17, L.P. | 4.9% | |||||
| Nea 17 GP, LLC | 4.9% | |||||
| Growth Equity Opportunities 18 VGE, LLC | 4.9% | |||||
| NEA 18 Venture Growth Equity, L.P. | 4.9% | |||||
| NEA Partners 18 VGE, L.P. | 4.9% | |||||
| Nea 18 Vge GP, LLC | 4.9% | |||||
| Forest Baskett | 4.9% | |||||
| Ali Behbahani | 4.9% | |||||
| Carmen Chang | 4.9% | |||||
| Anthony A. Florence, Jr. | 4.9% | |||||
| Mohamad H. Makhzoumi | 4.9% | |||||
| Edward T. Mathers | 4.9% | |||||
| Scott D. Sandell | 4.9% | |||||
| Paul Walker | 4.9% | |||||
| Rick Yang | 4.9% | |||||
|
Korro Bio, Inc.
13D/A
KRRO · 500946108
|
9.9% |
3/12/2026
Event 3/10/2026
|
||||
| New Enterprise Associates 17, L.P. | 9.9% | |||||
| NEA Partners 17, L.P. | 9.9% | |||||
| Nea 17 GP, LLC | 9.9% | |||||
| Forest Baskett | 9.9% | |||||
| Ali Behbahani | 9.9% | |||||
| Carmen Chang | 9.9% | |||||
| Anthony A. Florence, Jr. | 9.9% | |||||
| Mohamad H. Makhzoumi | 9.9% | |||||
| Edward T. Mathers | 9.9% | |||||
| Scott D. Sandell | 9.9% | |||||
| Paul Walker | 9.9% | |||||
| Rick Yang | 9.9% | |||||
|
SpyGlass Pharma, Inc.
13D
SGP · 85220G109
|
22.2% |
2/13/2026
Event 2/9/2026
|
||||
| New Enterprise Associates 17, L.P. | 22.2% | |||||
| NEA Partners 17, L.P. | 22.2% | |||||
| Nea 17 GP, LLC | 22.2% | |||||
| New Enterprise Associates 16, L.P. | 22.2% | |||||
| NEA Partners 16, L.P. | 22.2% | |||||
| Nea 16 GP, LLC | 22.2% | |||||
| Forest Baskett | 22.2% | |||||
| Ali Behbahani | 22.2% | |||||
| Carmen Chang | 22.2% | |||||
| Anthony A. Florence, Jr. | 22.2% | |||||
| Mohamad H. Makhzoumi | 22.2% | |||||
| Edward T. Mathers | 18.1% | |||||
| Scott D. Sandell | 22.2% | |||||
| Paul Walker | 22.2% | |||||
| Rick Yang | 18.1% | |||||
|
MBX Biosciences, Inc.
13D/A
MBX · 55287L101
|
8.1% |
11/10/2025
Event 11/6/2025
|
||||
| New Enterprise Associates 17, L.P. | 8.1% | |||||
| NEA Partners 17, L.P. | 8.1% | |||||
| Nea 17 GP, LLC | 8.1% | |||||
| Forest Baskett | 8.1% | |||||
| Ali Behbahani | 8.1% | |||||
| Carmen Chang | 8.1% | |||||
| Anthony A. Florence, Jr. | 8.1% | |||||
| Mohamad H. Makhzoumi | 8.1% | |||||
| Edward T. Mathers | 8.1% | |||||
| Scott D. Sandell | 8.1% | |||||
| Paul Walker | 8.1% | |||||
| Rick Yang | 8.1% | |||||
|
NeueHealth, Inc.
13D/A
NEUE · 10920V404
|
0% |
10/6/2025
Event 10/2/2025
|
||||
| New Enterprise Associates 15, L.P. | 0% | |||||
| NEA Partners 15, L.P. | 0% | |||||
| NEA 15 Opportunity Fund, L.P. | 0% | |||||
| NEA Partners 15-OF, L.P. | 0% | |||||
| Nea 15 GP, LLC | 0% | |||||
| New Enterprise Associates 16, L.P. | 0% | |||||
| NEA Partners 16, L.P. | 0% | |||||
| Nea 16 GP, LLC | 0% | |||||
| New Enterprise Associates 17, L.P. | 0% | |||||
| NEA Partners 17, L.P. | 0% | |||||
| Nea 17 GP, LLC | 0% | |||||
| NEA 18 Venture Growth Equity, L.P. | 0% | |||||
| NEA Partners 18 VGE, L.P. | 0% | |||||
| Nea 18 Vge GP, LLC | 0% | |||||
| Nea BH SPV, L.P. | 0% | |||||
| Nea BH SPV II, L.P. | 0% | |||||
| Nea BH SPV GP, LLC | 0% | |||||
| Forest Baskett | 0% | |||||
| Ali Behbahani | 0% | |||||
| Carmen Chang | 0% | |||||
| Anthony A. Florence, Jr. | 0% | |||||
| Mohamad H. Makhzoumi | 0% | |||||
| Edward T. Mathers | 0% | |||||
| Scott D. Sandell | 0% | |||||
| Paul Walker | 0% | |||||
| Rick Yang | 0% | |||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.